The pharmaceutical sector in India presents a intricate landscape, increasingly marked by concerns surrounding concentrated power. While the nation boasts a vibrant generic market, a few major companies hold a disproportionate portion of the market , sparking questions about rivalry and patient access to inexpensive drugs . This situation is fueled

The drug landscape in this country is increasingly characterized by a appearance toward market concentration, with a handful of prominent companies wielding significant control. These business giants, often bolstered by long-standing distribution networks and considerable brand recognition, present a difficult picture for competition and affordable

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces growing concerns about monopolies. A few dominant players control a significant percentage of the market, potentially hampering competition and driving up prices for consumers. This issue raises worries about the long-term impact on patient access to affor